- Details
- At the World Congress of Endourology and Uro-Technology, Mariah Hernandez presents a study examining the accuracy of CT reports in assessing stone burden stability in patients with medullary sponge kidney (MSK) and idiopathic urolithiasis. The research uses 3D Slicer software to measure volumetric stone burdens in 70 patients with reportedly stable CT scans. She concludes that volumetric assessmen...
|
- Details
- At the World Congress of Endourology and Uro-Technology, Seyedamirvala Saadat presents a study examining factors predicting spontaneous ureteral stone passage. The research, involving 199 patients with acute renal colic, assesses various stone characteristics and ureteral wall thickness using non-contrast CT scans. Initial univariate analysis shows that longer, wider, and denser stones surrounded...
|
- Details
- At the World Congress of Endourology and Uro-Technology, Jaime Landman presents the initial clinical experience with a combined robotic mini-percutaneous nephrolithotomy and ureteroscopic lithotripsy platform. The study demonstrates the procedure on a 49-year-old female with large kidney stones. Dr. Landman describes the Monarch Robotic Platform, which includes three robotic arms and a compact fie...
|
- Details
- At the World Congress of Endourology and Uro-Technology, Amir Lavasani presents a study on ureteral stricture formation following ureteroscopy, analyzing 550 cases from 2018 to 2022. The research examines the relationship between stricture formation and injury severity using the Post-Ureteroscopic Lesion Scale (PULS). The study concludes that stricture rates significantly increase with partial or...
|
- Details
- At the World Congress of Endourology and Uro-Technology, Bruce Gao presents the development and evaluation of a cost-effective force sensor for ureteroscopic applications called the Air Force 1. This device uses readily available materials to measure insertion forces during ureteral access sheath placement, aiming to prevent high-grade ureteral injuries. Dr. Gao concludes that this inexpensive met...
|
- Details
- At the World Congress of Endourology and Uro-Technology, Bruce Gao presents a study characterizing the lubricity of various urological catheters using a tribometer and a novel urethral tissue holder. The research tests 12 14 French catheters against porcine urethral segments, measuring the coefficient of friction to determine lubricity. Dr. Gao highlights that the Cook Medical Flexor Ureteral Acce...
|
- Details
- Louise Emmett discusses the novel copper-64 bisPSMA agent for prostate cancer imaging. She explains its unique features, including a 12-hour half-life and bifid peptide structure, which potentially offer improved imaging characteristics over existing PSMA agents. Dr. Emmett highlights early study results showing higher intensity uptake in cancer cells compared to gallium PSMA-11. The conversation...
|
- Details
- Neal Shore discusses a new 64Cu-SAR-bisPSMA PET diagnostic agent for prostate cancer imaging with Phillip Koo. Dr. Shore highlights the unique features of this compound, including its bivalent structure and longer half-life compared to existing PSMA PET agents. He explains how these characteristics allow for next-day imaging, potentially improving detection rates and clinical flexibility. Dr. Shor...
|
- Details
- John Babich discusses the potential of radiopharmaceuticals in cancer treatment. He emphasizes the importance of targeting and retention in tumor tissues, explaining the concept of therapeutic index and the company's "radioligand first, isotope second" approach. Dr. Babich highlights their work on FAP (fibroblast activation protein) and their Trillium technology, which aims to optimize drug delive...
|
- Details
- David Staskin discusses the COURAGE trial, a phase three study evaluating the efficacy of Vibegron, a beta-3 adrenergic receptor agonist, in men with BPH and persistent OAB symptoms despite alpha-blocker treatment. The study demonstrates significant improvements in various urinary symptoms, including micturitions, urgency episodes, and nocturia. Dr. Staskin highlights the drug's favorable safety p...
|
